Furthermore, the silencing of miR-92a could significantly suppress tumor invasion and growth [29], while the enhancement of miR-29a expression levels could also put a break on metastatic dissemination via targeting VEGFA, LOXL2, and LOX [52]. The gene discussed is LOXL2; the disease is neoplasm.